Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib
Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page
- CheckyesterdayChange DetectedAdded Hepatocellular carcinoma as a topic. Included a Resources section with a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing v3.4.1, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a 'Show glossary' option and updated metadata with 'Last Update Submitted that Met QC Criteria' and the Revision label to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page shows a minor version update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. No observable changes to the study details, layout, or functionality were detected on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib
Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.